热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD4 Antibody
产品名称：
PE/Cyanine7 anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100421
产品应用：
100421
[价格]
规格 价格 库存
25µg ￥ 1056 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation.?Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  6. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  7. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  8. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  9. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  10. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  11. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  12. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  13. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  14. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  15. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  16. Fernandes RA, et al. 2020. eLife. 9:e58463.. PubMed
  17. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  18. Crespo ?C, et al. 2020. Cell. 182(5):1125-1139. PubMed
  19. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  20. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  21. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  22. Diao L, et al. 2022. iScience. 25:105511. PubMed
  23. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  24. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  25. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  26. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  27. Kaufmann U et al. 2019. Cell metabolism. 29(5):1104-1118 . PubMed
  28. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  29. Rolla S, et al. 2010. J Immunol. 184:6124. PubMed
  30. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  31. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  32. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  33. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  34. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  35. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  36. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  37. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  38. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  39. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  40. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  41. Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
  42. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  43. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  44. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  45. An J, et al. 2022. iScience. 25:103570. PubMed
  46. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  47. Ohmichi Y, et al. 2011. J Exp Med . 208:1015. PubMed
  48. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  49. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  50. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  51. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  52. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  53. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  54. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  55. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  56. Lee P, et al. 2014. J Immunol. 192:178. PubMed
  57. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  58. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  59. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  60. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  61. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  62. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  63. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  64. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  65. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  66. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  67. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  68. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  69. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  70. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  71. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  72. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  73. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  74. XS R, et al. 2015. Diabetes. 64 90. PubMed
  75. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  76. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  77. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  78. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  79. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  80. Busse DC, et al. 2020. J Virol. 94:00:00. PubMed
  81. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  82. Lebel M?, et al. 2020. Nat Commun. 3.051388889. PubMed
  83. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  84. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  85. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  86. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  87. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  88. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  89. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  90. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  91. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  92. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  93. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  94. Li C, et al. 2018. Cell. 174:285. PubMed
  95. Nakornpakdee Y, et al. 2018. Asian Pac J Allergy Immunol. 36:265. PubMed
  96. Sch?nberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  97. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  98. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  99. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  100. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  101. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  102. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  103. Prüss H, et al. 2017. Nat Neurosci. 10.1038/nn.4643. PubMed
  104. Kimura S, et al. 2020. Am J Transplant. 20:977. PubMed
  105. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  106. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  107. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  108. Ambrosino E, et al. 2006. Cancer Res . 66:7734. PubMed
  109. Nagamata S, et al. 2019. Sci Rep. 9:3911. PubMed
  110. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  111. RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed
  112. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  113. Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed
  114. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  115. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  116. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
  117. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  118. Sch?fer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  119. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  120. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  121. Simula L, et al. 2022. Mol Oncol. 16:188. PubMed
  122. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  123. Groves HT, et al. 2020. MBio. 11:e03236-19. PubMed
  124. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  125. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  126. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_312706 (BioLegend Cat. No. 100421) AB_312707 (BioLegend Cat. No. 100422)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线